Review: Cholesterol-lowering treatment with statins reduces all-cause mortality in persons at risk: COMMENTARY

Rembold, Christopher
May 2006
ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p62
Academic Journal
The article presents comments of the author on a study which found that cholesterol-lowering treatment with statins reduces all-cause mortality in persons at risk. The meta-analysis by the Cholesterol Treatment Trialists' Collaboration confirms that lowering LDL cholesterol with statins significantly reduces coronary heart disease mortality, myocardial infarction stroke and coronary revascularization without increasing nonvascular mortality or cancer incidence. Clinical trials showing that statins are superior to other lipid-lowering therapies do not exist.


Related Articles

  • Review: Cholesterol-lowering treatment with statins reduces all-cause mortality in persons at risk.  // ACP Journal Club;May/Jun2006, Vol. 144 Issue 3, p62 

    The article discusses a study which found that cholesterol-lowering treatment with statins reduces all-cause and coronary heart disease mortality in persons at risk. Unconfounded randomized controlled trials (RCTs) that compared a statin with a control condition were chosen for the study. 14...

  • Oxidized low-density lipoprotein cholesterol and the ratio in the diagnosis and evaluation of therapeutic effect in patients with coronary artery disease. Huang, Huiling; Ma, R.; Liu, Dan; Liu, Chen; Ma, Yuedong; Mai, Weiyi; Dong, Yugang // Disease Markers;2012, Vol. 33 Issue 6, p295 

    Objective: The purpose of the present study was to investigate the value of ox-LDL and oxidation ratio of LDL (ox-LDL/TC, ox-LDL/HDL-C and ox-LDL/LDL-C) in diagnosis and prognosis evaluation in CAD patients. Also, we aimed to observe the effect of statins on reducing level of ox-LDL and...

  • Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes. Cannon, Christopher P.; Braunwald, Eugene; McCabe, Carolyn H.; Rader, Daniel J.; Rouleau, Jean L.; Belder, Rene; Joyal, Steven V.; Hill, Karen A.; Pfeffer, Marc A.; Skene, Allan M. // New England Journal of Medicine;4/8/2004, Vol. 350 Issue 15, p1495 

    Background: Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the optimal level of low-density lipoprotein (LDL) cholesterol is unclear. Methods: We enrolled 4162 patients who had been hospitalized for an acute coronary syndrome within the preceding 10 days and...

  • STRESS FROM CRP vs. LDL AND INFLAMMATION. Rosch, Paul J. // Health & Stress;Oct2010, Issue 10, p1 

    The article discusses health problems including heart disease, stress and inflammation. It notes that cholesterol and fatty foods do not cause heart attacks or coronary atherosclerosis likewise statins may benefit patients who have had a myocardial infarction. It states that some authorities...

  • Independent Nurse: Clinical CVD - Mixed results from latest research. Polak, Monika // GP: General Practitioner;12/9/2005, p105 

    This article presents results from trials investigating the treatment of heart diseases. Clinicians are familiar with the need to titrate up statins where possible to achieve maximum therapeutic benefit. A major international trial aimed to compare the cardiovascular risk reduction achievable...

  • Emerging Therapies and Their Role in Comprehensive Lipid Management. Vinall, Maria // MD Conference Express;Oct2011, p6 

    The article focuses on the clinical trials which aimed to evaluate low-density lipoprotein cholesterol (LDL-C) targets and assess their significance on treatment approaches. It mentions the result of the PROVE-IT trial which support intensive statin therapy after acute coronary syndrome (ACS),...

  • Atorvastatin Efficacy in the Prevention of Cardiovascular Events in Patients with Diabetes Mellitus and/or Metabolic Syndrome. Arca, Marcello // Drugs;2007 Supplement 1, Vol. 67, p43 

    Several large-scale clinical trials have assessed the efficacy of atorvastatin in the primary and secondary prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome. In primary prevention, CARDS (Collaborative Atorvastatin Diabetes Study) showed that...

  • Coronary Risk Factors in the Elderly: Their Interactions and Treatment. Carbonin, Pierugo; Zuccal�, Giuseppe; Marzetti, Emanuele; Lo Monaco, Maria Rita // Current Pharmaceutical Design;Nov2003, Vol. 9 Issue 29, p2465 

    Coronary disease is currently a major cause of disability and mortality in older populations. Due to several factors - including increased noncardiovascular mortality, atypical presentation of coronary events, selective survival, and, possibly, clustering of protective genetic traits - the...

  • A new framework for reverse cholesterol transport: Non-biliary contributions to reverse cholesterol transport. Temel, Ryan E.; Mark Brown, J. // Annals of Gastroenterology & Hepatology;2011, Vol. 9 Issue 93, p5946 

    Reduction of low-density lipoprotein-cholesterol through statin therapy has only modestly decreased coronary heart disease (CHD)-associated mortality in developed countries, which has prompted the search for alternative therapeutic strategies for CHD. Major efforts are now focused on therapies...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics